Literature DB >> 3622317

The haemodynamic and anti-ischaemic effects of a single tablet of 80 mg isosorbide dinitrate in slow-release formulation and a review of nitrate tolerance.

S Silber, A C Vogler, K H Krause, K Theisen.   

Abstract

There is increasing evidence that relatively constant plasma nitrate concentrations induced by 3-times-daily administration of isosorbide dinitrate can lead to an attenuation or even complete loss of the drug's anti-ischaemic effects (nitrate tolerance). We therefore assessed the dependence of nitrate tolerance development from the haemodynamic and anti-ischaemic effects of a slow-release tablet formulation of isosorbide dinitrate 80 mg, administered according to different daily dosage regimens in patients with angina. It was found that a once-daily regimen, with its consequent peak and trough plasma nitrate concentrations, is capable of protecting against exercise-induced myocardial ischaemia for about 12 hours with the circumvention of nitrate tolerance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3622317     DOI: 10.2165/00003495-198700334-00014

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  64 in total

1.  Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine.

Authors:  M D Winniford; P L Kennedy; P J Wells; L D Hillis
Journal:  Circulation       Date:  1986-01       Impact factor: 29.690

2.  Anti-ischemic effects of an 80-mg tablet of isosorbide dinitrate in sustained-release form before and after 2 weeks treatment with 80 mg once daily or twice daily.

Authors:  S Silber; K H Krause; C Garner; K Theisen; H Jahrmärker
Journal:  Z Kardiol       Date:  1983

3.  The brief saga of transdermal nitroglycerin discs: paradise lost?

Authors:  J Abrams
Journal:  Am J Cardiol       Date:  1984-07-01       Impact factor: 2.778

4.  [Rapid attenuation of effects of isosorbide dinitrate during long-term treatment of chronic congestive heart failure].

Authors:  R Blasini; K L Froer; G Blümel; W Rudolph
Journal:  Herz       Date:  1982-08       Impact factor: 1.443

5.  Organic nitrates: tolerance at the level of the vascular smooth muscle.

Authors:  A G Herman; M G Bogaert
Journal:  Arch Int Pharmacodyn Ther       Date:  1971-07

6.  Sublingual isosorbide dinitrate therapy versus sublingual acebo in angina pectoris.

Authors:  W S Aronow; H M Chesluk
Journal:  Circulation       Date:  1970-05       Impact factor: 29.690

7.  Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy.

Authors:  J O Parker; K A VanKoughnett; H L Fung
Journal:  Am J Cardiol       Date:  1984-07-01       Impact factor: 2.778

8.  Prevention and reversal of tolerance to nitroglycerine with N-acetylcysteine.

Authors:  J Torresi; J D Horowitz; G J Dusting
Journal:  J Cardiovasc Pharmacol       Date:  1985 Jul-Aug       Impact factor: 3.105

9.  Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use.

Authors:  D T Danahy; W S Aronow
Journal:  Circulation       Date:  1977-08       Impact factor: 29.690

Review 10.  Nitrate tolerance.

Authors:  C V Leier
Journal:  Am Heart J       Date:  1985-07       Impact factor: 4.749

View more
  3 in total

Review 1.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

2.  Abrupt cessation of short-term continuous treatment with isosorbide dinitrate may cause a rebound increase in silent myocardial ischaemia in patients with stable angina pectoris.

Authors:  S Y Martsevich; N Koutishenko; V I Metelitsa
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

Review 3.  Nitrate tolerance. A review of the evidence.

Authors:  J T Flaherty
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.